CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 43 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-18 | SAHAREK JOHN P. Chief Commercial Officer | Option exercise · Performance Stock Unit | −277,200 | 0 | ||
| 2023-07-18 | BOLL ANDREW R. Chief Financial Officer | Option exercise | +346,500 | 670,519 | ||
| 2023-07-18 | BOLL ANDREW R. Chief Financial Officer | Shares withheld for taxes | −136,350 | $18.23 | $2.5M | 534,169 |
| 2023-07-18 | BOLL ANDREW R. Chief Financial Officer | Option exercise · Performance Stock Unit | −346,500 | 0 | ||
| 2023-06-21 | Van Horn R. Lawrence Director | Grant or award · RSU | +7,744 | 7,744 | ||
| 2023-06-21 | Sternberg Perry J. Director | Grant or award · RSU | +7,744 | 7,744 | ||
| 2023-06-21 | Sparks Teresa Director | Grant or award · RSU | +7,744 | 7,744 | ||
| 2023-06-21 | Makary Martin A. Director | Grant or award · RSU | +7,744 | 7,744 | ||
| 2023-04-03 | BAUM MARK L Chief Executive Officer | Option exercise | +180,000 | $8.99 | $1.6M | 1,664,962 |
| 2023-04-03 | BAUM MARK L Chief Executive Officer | Shares withheld for taxes | −117,633 | $20.97 | $2.5M | 1,547,329 |
| 2023-04-03 | BAUM MARK L Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −180,000 | 0 | ||
| 2023-04-03 | BAUM MARK L Chief Executive Officer | Grant or award · Restricted Stock Unit | +762,300 | 762,300 | ||
| 2023-04-03 | SAHAREK JOHN P. Chief Commercial Officer | Grant or award · Restricted Stock Unit | +277,200 | 277,200 | ||
| 2023-04-03 | BOLL ANDREW R. Chief Financial Officer | Grant or award · Restricted Stock Unit | +346,500 | 346,500 | ||
| 2023-03-31 | BOLL ANDREW R. Chief Financial Officer | Option exercise | +90,000 | $6.00 | $540K | 358,461 |
| 2023-03-31 | BOLL ANDREW R. Chief Financial Officer | Shares withheld for taxes | −34,442 | $21.16 | $729K | 324,019 |
| 2023-03-31 | BOLL ANDREW R. Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −90,000 | 0 | ||
| 2023-01-02 | BOLL ANDREW R. Chief Financial Officer | Option exercise | +23,000 | 278,063 | ||
| 2023-01-02 | BOLL ANDREW R. Chief Financial Officer | Shares withheld for taxes | −9,602 | $14.76 | $142K | 268,461 |
| 2023-01-02 | BOLL ANDREW R. Chief Financial Officer | Option exercise · Restricted Stock Unit | −23,000 | 0 |
Page 6 of 17 · 336 trades